# Median Effective Dose of Rocuronium for the Prevention of Myofibrillation Caused by the Injection of Succinylcholine

> **NCT05909696** · NA · COMPLETED · sponsor: **Yangzhou University** · enrollment: 60 (actual)

## Conditions studied

- Succinylcholine
- Myofibrillation

## Interventions

- **DRUG:** rocuronium

## Key facts

- **NCT ID:** NCT05909696
- **Lead sponsor:** Yangzhou University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-01
- **Primary completion:** 2023-10-30
- **Final completion:** 2023-10-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05909696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05909696, "Median Effective Dose of Rocuronium for the Prevention of Myofibrillation Caused by the Injection of Succinylcholine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05909696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*